Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_assertion type Assertion NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_head.
- NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_assertion description "[According to multivariate analysis, HER2-positive status and trastuzumab treatment, high Ki-67 index, and hormone receptor negativity remained independent risk factors for the development of CNS metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_provenance.
- NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_assertion evidence source_evidence_literature NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_provenance.
- NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_assertion SIO_000772 21509760 NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_provenance.
- NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_assertion wasDerivedFrom befree-20140225 NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_provenance.
- NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_assertion wasGeneratedBy ECO_0000203 NP585740.RA7Fs9b_noGKgkggA46eoqNQUUvnBRF29VJgku63iYg7I130_provenance.